Granite Point Capital Management’s Celldex Therapeutics CLDX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-109,095	Closed	-$1.42M	–	118
2020 Q2	$1.42M	Buy	+109,095	New	+$1.42M	0.07%	57